How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach

How to deal with multiple treatment or d

How to deal with multiple treatment or dose groups in randomized clinical trials?

✍ L.A. Hothorn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

The addition of interferon or high dose

The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma : Phase III Eastern Cooperative Oncology Group clinical trial EST 9486

✍ Martin M. Oken; Traci Leong; Raymond E. Lenhard Jr.; Philip R. Greipp; Neil E. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. Interferon (IFN) has demonstrated activity in the treatment of patients with multiple myeloma. A previous Eastern Cooperative Oncology Group (ECOG) study suggested that the rates of complete response (CR) and survival were increased with a regimen that alternated IFN with chemothera